Skip to content

PTSD: all studies

Page 137 of 211: studies 1,361 to 1,370 of 2,103, newest first. Back to the PTSD overview

Research

Mindfulness‐Oriented Recovery Enhancement: Implementing an evidence‐based intervention for chronic pain, opioid use, and opioid addiction in clinical settings

British Journal of Clinical Pharmacology July 24, 2024 Eric L Garland

The opioid crisis emerged in part due to the overprescribing of opioid analgesics for chronic pain. Although not the only source of the current epidemic of opioid use disorder (OUD), the prescription of opioids for chronic pain remains one vector for the development of opioid misuse and OUD. However, opioid tapering is not appropriate for all patients, and some patients may need to remain on...

Integrating Psychedelics into Groupwork: A Culturally Responsive Model for the Counseling Profession

Psychoactives July 18, 2024 Isaac Burt

Psychedelics, combined with talk therapy, indicate promise with challenging clients, such as those struggling with PTSD. Furthermore, groupwork, with the emphasis on social connections, can be an effective modality. There appears, however, little movement with integrating psychedelics with professional counseling and even less in groupwork. Societal perceptions of psychedelics and the concern...

DOI: 10.3390/psychoactives3030022 (opens in new tab) Psychotherapist Psychoanalysis Applied psychology

Immediate Effects of Mindful Awareness in Body-oriented Therapy as an Adjunct to Medication for Opioid Use Disorder.

Research Square July 15, 2024 Cynthia U Price, Kenneth C Pike, Anna Treadway et al. preprint

While effective, medication for opioid use disorder (MOUD) treatment outcomes can be limited by co-occurring polysubstance use, mental health and chronic pain conditions. Interoceptive training may facilitate well-being and support medication treatment for MOUD. This study examined the pre-post effects of the mindfulness-based intervention Mindful Awareness in Body-oriented Therapy (MABT) as an...

The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacology Bulletin July 8, 2024 Justin Faden, Leslie Citrome 29 citations

Since the last edition of the Black Book, several innovative agents have been approved or are poised to be approved in the coming year. These include novel antidepressants, the first muscarine agonist for the treatment of schizophrenia, the first psychedelic which may be approved for the treatment of PTSD (Post Traumatic Stress Disorder), and the first disease modifying drug for the treatment...

DOI: 10.1177/2045125320968658 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Psychiatric medication Breakthrough therapies +1

A reasoned action approach to meditation behavior among cadets at the United States Military Academy.

Military psychology : the official journal of the Division of Military Psychology, American Psychological Association July 3, 2024 Ryan G. Erbe, Peter Meindl, Elise M. Dykhuis et al.

Military members face emotion-regulation challenges due to the high-pressure nature of the profession as evidenced by rates of mental health issues within military populations. Identifying behaviors that are efficient and effective at promoting emotion-regulation and helping military members adopt them is essential. Recently, meditation has been shown to reduce stress, enhance attention control...

Cognitive Behavior Therapy vs Mindfulness in Treatment of Prolonged Grief Disorder: A Randomized Clinical Trial.

JAMA Psychiatry July 1, 2024

Importance: Although grief-focused cognitive behavior therapies are the most empirically supported treatment for prolonged grief disorder, many people find this treatment difficult. A viable alternative for treatment is mindfulness-based cognitive therapy. Objective: To examine the relative efficacies of grief-focused cognitive behavior therapy and mindfulness-based cognitive therapy to reduce...

What is needed for the roll-out of psychedelic treatments?

Current Opinion in Psychiatry July 1, 2024 Stephen N. Xenakis, Scott Shannon 5 citations

The pace of psychedelic treatments continues to increase. Regulation and coherent clinical guidance have not been established. A philosophical divide limits effective resolution of a practice delivery quandary: is this primarily a pharmacological or psychotherapeutic intervention? Lykos (formerly MAPS) has submitted its new drug application (NDA) request to the FDA for...

The Impact of Mindfulness Therapy on Stress and Anxiety in Patients with Covid-19

روانشناسی و روانپزشکی شناخت June 30, 2024 Ziba Karimi, Mehrdad Mazaheri, Sana Nourimoghadam

Introduction: Covid-19 has had short-term and long-term negative psychological consequences on human societies. The results of numerous studies indicate significant effects on people's health, such as anxiety, stress, depression, insomnia, and PTSD. Aim: The purpose of the present study was the effectiveness of mindfulness therapy on stress and anxiety in patients with covid-19. Method: The...

REPETITION OF SPIRITUAL MANTRA MEDITATION: A REVIEW

Jurnal Kajian Islam dan Turath Antara - Bidang June 30, 2024

Abstract Introduction: Studies on spiritual mantra meditation represent a growing field. Objectives: This review paper aims on several repetitions of spiritual mantra meditation including the practices and its effect on health. Methods: The selected papers were searched by using PubMed and Scopus databases from 2007-2017. The terms used were ‘mantra’, ‘chanting’, ‘religious chanting’, ‘zikr’ or...

IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?

Journal of Pakistan Psychiatric Society June 30, 2024 Nauman Ashraf 1 citation

Psychedelics, substances known to alter perception, mood, and consciousness, have been used across various cultures for centuries, often in religious ceremonies to facilitate spiritual experiences. Lysergic acid diethylamide (LSD) was used clinically from the 1950s until its ban in 1967. Recently, there has been a resurgence of interest in psychedelics for treating mental health disorders such...